Dose-Ranging Study of Pradefovir in Patients With Compensated Hepatitis B

NCT00230503 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

220

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis B, Chronic

Interventions

DRUG: pradefovir mesylate
DRUG: adefovir dipivoxyl

Sponsor

Bausch Health Americas, Inc.